Kevin Kotler 's healthcare fund Broadfin Capital, the top performing fund in our database this year based on the calculated returns of its public equity positions in companies with a $1 billion+ market cap, has had it with the childish gamesmanship of Cardica, Inc. 's Board of Directors. According to a recent filing with the SEC, the fund is going to issue a proxy statement and an accompanying proxy card at the upcoming shareholders meeting in order to solicit votes for the nomination of eight candidates for election to Cardica's Board of Directors.